ClinicalTrials.Veeva

Menu

Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer

S

State Key Laboratory of Cancer Biology

Status

Unknown

Conditions

Gastric Cancer

Treatments

Diagnostic Test: pre-endoscopic screening risk assessment

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT03484949
xjtu-20170816

Details and patient eligibility

About

Gastric cancer is one of the most common malignancies in China. Early detection is critical for gastric cancer management. However, the diagnosis rate of patients with early gastric cancer is still low. Therefore, the investigator design this study to access whether pre-endoscopic screening risk assessment of genetic and environmental risk factors could improve early gastric cancer diagnosis rate.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Age 18-60. 2.Signed informed consent

Exclusion criteria

  • 1.Severe back ground disease including malignancy. 2.State after gastric surgery. 3.COPD, CHF, CRF and any disease with respiratory disturbances. 4.Deviation of the nasal septum, lack of venous access at the dorsum of the hand or any other technical problem prevents gastric acid collection or base excess evaluation.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,000 participants in 2 patient groups

pre-endoscopic screening risk assessment
Experimental group
Treatment:
Diagnostic Test: pre-endoscopic screening risk assessment
routine screening
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Dake Chu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems